ARTICLE SUMMARY:
SPR Therapeutics has developed a peripheral nerve stimulation therapy to address chronic pain syndromes in the back, limbs, and shoulder, as well as acute pain following joint replacement surgery. Delivered percutaneously for 30 days, the company’s FDA-cleared, single-use disposable PNS platform has the potential to revolutionize pain management, offering a device-based alternative to highly addictive opioid drugs.
Pain management is one of the greatest unmet needs in medicine, with more than 100 million Americans suffering from chronic pain every year.
